Status:

COMPLETED

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Lead Sponsor:

Abbott

Conditions:

Crohn's Disease

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or d...

Eligibility Criteria

Inclusion

  • Males and females between the ages of 18 and 75 who are diagnosed with mild to moderate Crohn's disease (defined by a CDAI \[Crohn's Disease Activity Index\] score of 220 and 450)
  • Normal lab parameters
  • Are willing to give informed consent
  • Have previously used and either were intolerant to or lost response to infliximab

Exclusion

  • History of certain types of cancer
  • Diagnosis of ulcerative colitis
  • Pregnant female or breast feeding subjects
  • Known obstructive strictures
  • Surgical bowel resection in the past 6 months
  • History of listeria, human immunodeficiency virus (HIV), central nervous system demyelinating disease or untreated TB (tuberculosis)
  • History of poorly controlled medical conditions
  • Specific doses and durations of Crohn's medications
  • Subjects that have previously used infliximab and have never clinically responded unless primary non-response was due to a treatment limiting reaction to infliximab

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00105300

Start Date

October 1 2004

Last Update

August 15 2006

Active Locations (56)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (56 locations)

1

Clinical Research Associates

Huntsville, Alabama, United States, 35801

2

Capitol Gastroenterology Consultants Medical Group, Inc.

Roseville, California, United States, 95661

3

Medical Associates Research Group

San Diego, California, United States, 92123

4

Sharp Rees-Stealy Medical Group

San Diego, California, United States, 92123